The delivery of Vaccination programmes for HPV will have a profound impact on cervical screening programmes as we know them. Screening for the vaccinated cohort will need to focus on HPV based screening. How best to integrated these developments is the subject of much discussion and debate. Xavier Bosch tells us more.
Xavier Bosch discusses how to maximise the impact of new developments in reducing cervical cancer across the world.